InvestorsHub Logo
Followers 10
Posts 1104
Boards Moderated 0
Alias Born 12/07/2012

Re: None

Tuesday, 03/21/2017 8:28:02 AM

Tuesday, March 21, 2017 8:28:02 AM

Post# of 38634

The other thing we are trying to do is in the future consider registration of our products in our own label and trying to put products in the market, particularly the ANDAs (Abbreviated New Drug Application), the generic products, to sell them ourselves. Those are the challenges that we see from day to day when we’re trying to put products on the market.



I wonder if this is the plan with Keppra and Glucophage


But we filed recently two products in Canada.



No PR, would be nice to know which two. Whats approval times for Canada like?


Its nice to see a increase in communication from the company. I don't know why some of it isn't issued in PR's though. The submissions to Canada seem to be PR worthy to me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News